Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Aileron partners Stapled Peptide platform with Roche; terminated

Executive Summary

Securing its first ever partner, Aileron Therapeutics Inc. (peptide stabilizing technology) has agreed to work with Roche on Stapled Peptide drug candidates against five targets in the Big Pharma's therapeutic areas of interest--cancer, virology, inflammation, metabolic disease, and neurology.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • R&D and Marketing (Licensing)

Related Companies